Literature DB >> 30964573

JAK/STAT pathway modulation: Does it work in dermatology?

Özgür Gündüz1.   

Abstract

Janus kinase-signal transducer and activator of transcription (JAK/STAT)-is an intracellular signaling pathway, which plays a key role in downstream transmission of extracellular signals from cell membrane to the cell nucleus. This pathway is activated by cytokines, which participate in inflammation, innate and acquired immune responses, and also cell growth. Recent studies point out possible disturbances in JAK/STAT pathway in various inflammatory and autoimmune skin diseases, such as atopic dermatitis, psoriasis, alopecia areata. Several molecules that modulate-inhibit-this pathway are currently under investigation for the evaluation of their clinical use in dermatological diseases. A brief overview of the therapeutical use of JAK/STAT inhibitors in dermatology will be provided here.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Jakinibs; Janus kinase (JAK); alopecia areata; anitinflammatory; atopic dermatitis; immunomodulation; psoriasis; signal transducer and activator of transcription (STAT)

Mesh:

Substances:

Year:  2019        PMID: 30964573     DOI: 10.1111/dth.12903

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  5 in total

Review 1.  Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis.

Authors:  Rhea Singh; Courtney E Heron; Rima I Ghamrawi; Lindsay C Strowd; Steven R Feldman
Journal:  Immunotargets Ther       Date:  2020-11-10

2.  RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer.

Authors:  Chuanyu Cheng; Dongkui Song; Yudong Wu; Bingqian Liu
Journal:  Front Mol Biosci       Date:  2020-08-31

Review 3.  Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis.

Authors:  Spandana Rajendra Kopalli; Venkata Prakash Annamneedi; Sushruta Koppula
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

Review 4.  The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review.

Authors:  Aikaterini Tsiogka; Maria Kyriazopoulou; George Kontochristopoulos; Electra Nicolaidou; Alexander Stratigos; Dimitris Rigopoulos; Stamatios Gregoriou
Journal:  J Clin Med       Date:  2022-07-29       Impact factor: 4.964

5.  Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis.

Authors:  Dimitra Koumaki; Vasiliki Koumaki; Eleni Lagoudaki; George Bertsias
Journal:  Eur J Case Rep Intern Med       Date:  2019-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.